• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Modernizing Toxicology

Description: Facilitate and qualify more predictive non-clinical toxicology testing methods for evaluating the safety of FDA-regulated products in support of the Agency-wide advancing regulatory science initiative. The goal of the project is to develop more predictive non-clinical safety models to improve public health.

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date

A. Partner with the Defense Advanced Research Projects Agency (DARPA) and the National Institutes of Health (NIH) on development of human on a chip models

 

1. Review submitted proposals to DARPA Request for Application (RFA)

1/31/2012

Completed 1/13/2012

2. Review submitted proposals to NIH

3/31/2012

Completed 4/20/2012

3. Hold workshop on Human on a Chip

12/31/2012

(1/25/2013)

(5/10/2013)

Completed 5/10/2013

B. Host a workshop on Reproductive and Developmental Toxicology Testing

4/16/2012

Completed 4/16/2012

C. Sign MOU with Society of Toxicology

6/30/2012

Completed 4/16/2012

D. Submit papers from the Reproductive and Developmental Toxicology Testing workshop in conjunction with co-sponsors

12/31/2012

Completed 9/30/2012

Footnotes

  • The dates in italics under the milestone due dates are modified milestone due dates which had to be updated due to real-time delays. The milestone status reflects the revised dates.

Key Projects Legend

Milestone StatusDefinition
Not Yet StartedWork for specific milestone has not yet been started.
CompletedMilestone and/or overall project is completed.
On TrackMilestone - On track for completion by milestone deadline. Quarter status - Project is on track for completion based on overall milestone status.
On HoldMilestone - On hold, but deadline for completion has not passed. Quarter status - Project is on hold, based on overall milestone status.
DelayedMilestone - Delayed as it has not been completed and deadline has passed. Quarter status - Project is delayed based on overall milestone status.

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.